1. TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA (M.L.O., R.P.G., E.K., K.A.I., M.S.S.).
2. Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland (S.F.).
3. Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands (E.S.G.S.).
4. Polyclinic for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Germany (I.G.-B.).
5. Amgen, Thousand Oaks, CA (A.L.P., S.M.W.).
6. Center for Preventive Cardiology, 3rd Internal Medicine Clinic, University General Hospital and Charles University 1st Medical Faculty, Prague, Czech Republic (R.C.).
7. National Cardiology Research Center, Moscow, Russia (M.V.E.).
8. Department of Cardiology, Leiden University Medical Center, The Netherlands (J.W.J.).
9. Department of Cardiology, Aarhus University Hospital and Department of Clinical Medicine, Health, Aarhus University, Denmark (H.K.J.).
10. Cardiovascular Division, Hacettepe University, Ankara, Turkey (S.L.T.).
11. Cardiology Division, University of Geneva, Switzerland (F.M.).
12. 3rd Department of Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital and Sigmund Freud University, Medical Faculty, Vienna, Austria (K.H.).
13. Imperial College London, UK (P.S.S.).
14. Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Australia (A.C.K.).
15. Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Norway (T.R.P.).